BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 25486521)

  • 1. Metabolomics analysis of metabolic effects of nicotinamide phosphoribosyltransferase (NAMPT) inhibition on human cancer cells.
    Tolstikov V; Nikolayev A; Dong S; Zhao G; Kuo MS
    PLoS One; 2014; 9(12):e114019. PubMed ID: 25486521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications.
    Tan B; Young DA; Lu ZH; Wang T; Meier TI; Shepard RL; Roth K; Zhai Y; Huss K; Kuo MS; Gillig J; Parthasarathy S; Burkholder TP; Smith MC; Geeganage S; Zhao G
    J Biol Chem; 2013 Feb; 288(5):3500-11. PubMed ID: 23239881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer Cells.
    Tan B; Dong S; Shepard RL; Kays L; Roth KD; Geeganage S; Kuo MS; Zhao G
    J Biol Chem; 2015 Jun; 290(25):15812-15824. PubMed ID: 25944913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivatization of the tricarboxylic acid intermediates with O-benzylhydroxylamine for liquid chromatography-tandem mass spectrometry detection.
    Tan B; Lu Z; Dong S; Zhao G; Kuo MS
    Anal Biochem; 2014 Nov; 465():134-47. PubMed ID: 25102203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry.
    Hirayama A; Kami K; Sugimoto M; Sugawara M; Toki N; Onozuka H; Kinoshita T; Saito N; Ochiai A; Tomita M; Esumi H; Soga T
    Cancer Res; 2009 Jun; 69(11):4918-25. PubMed ID: 19458066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics analysis reveals distinct profiles of nonmuscle-invasive and muscle-invasive bladder cancer.
    Sahu D; Lotan Y; Wittmann B; Neri B; Hansel DE
    Cancer Med; 2017 Sep; 6(9):2106-2120. PubMed ID: 28766915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal toxicity, in vivo and in vitro, associated with inhibition of nicotinamide phosphoribosyltransferase.
    Zabka TS; Singh J; Dhawan P; Liederer BM; Oeh J; Kauss MA; Xiao Y; Zak M; Lin T; McCray B; La N; Nguyen T; Beyer J; Farman C; Uppal H; Dragovich PS; O'Brien T; Sampath D; Misner DL
    Toxicol Sci; 2015 Mar; 144(1):163-72. PubMed ID: 25505128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.
    Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B
    Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid.
    Tarrant JM; Dhawan P; Singh J; Zabka TS; Clarke E; DosSantos G; Dragovich PS; Sampath D; Lin T; McCray B; La N; Nguyen T; Kauss A; Dambach D; Misner DL; Diaz D; Uppal H
    Toxicol Mech Methods; 2015 Mar; 25(3):201-11. PubMed ID: 25894564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NAMPT pathway by FK866 activates the function of p53 in HEK293T cells.
    Thakur BK; Dittrich T; Chandra P; Becker A; Lippka Y; Selvakumar D; Klusmann JH; Reinhardt D; Welte K
    Biochem Biophys Res Commun; 2012 Aug; 424(3):371-7. PubMed ID: 22728882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic Reprogramming in Hep3B Cells with Aflatoxin B1 Exposure.
    Wang S; Yang X; Liu F; Wang X; Zhang X; He K; Wang H
    Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34072178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Nampt in gastric cancer and chemopotentiating effects of the Nampt inhibitor FK866 in combination with fluorouracil.
    Bi TQ; Che XM; Liao XH; Zhang DJ; Long HL; Li HJ; Zhao W
    Oncol Rep; 2011 Nov; 26(5):1251-7. PubMed ID: 21743967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct Metabolomic Profiles of Papillary Thyroid Carcinoma and Benign Thyroid Adenoma.
    Xu Y; Zheng X; Qiu Y; Jia W; Wang J; Yin S
    J Proteome Res; 2015 Aug; 14(8):3315-21. PubMed ID: 26130307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-platform comparison of methods for quantitative metabolomics of primary metabolism.
    Büscher JM; Czernik D; Ewald JC; Sauer U; Zamboni N
    Anal Chem; 2009 Mar; 81(6):2135-43. PubMed ID: 19236023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of NAMPT decreases cell growth and enhances susceptibility to oxidative stress.
    Xu R; Yuan Z; Yang L; Li L; Li D; Lv C
    Oncol Rep; 2017 Sep; 38(3):1767-1773. PubMed ID: 28714034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.
    Galli U; Travelli C; Massarotti A; Fakhfouri G; Rahimian R; Tron GC; Genazzani AA
    J Med Chem; 2013 Aug; 56(16):6279-96. PubMed ID: 23679915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nicotinamide phosphoribosyltransferase (NAMPT) as a therapeutic strategy in cancer.
    Sampath D; Zabka TS; Misner DL; O'Brien T; Dragovich PS
    Pharmacol Ther; 2015 Jul; 151():16-31. PubMed ID: 25709099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding alternative fluxes/effluxes through comparative metabolic pathway analysis of phylum actinobacteria using a simplified approach.
    Verma M; Lal D; Saxena A; Anand S; Kaur J; Kaur J; Lal R
    Gene; 2013 Dec; 531(2):306-17. PubMed ID: 24055419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Response to NAD Depletion across Cell Lines Is Highly Variable.
    Xiao Y; Kwong M; Daemen A; Belvin M; Liang X; Hatzivassiliou G; O'Brien T
    PLoS One; 2016; 11(10):e0164166. PubMed ID: 27711204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
    Zheng X; Bair KW; Bauer P; Baumeister T; Bowman KK; Buckmelter AJ; Caligiuri M; Clodfelter KH; Feng Y; Han B; Ho YC; Kley N; Li H; Liang X; Liederer BM; Lin J; Ly J; O'Brien T; Oeh J; Oh A; Reynolds DJ; Sampath D; Sharma G; Skelton N; Smith CC; Tremayne J; Wang L; Wang W; Wang Z; Wu H; Wu J; Xiao Y; Yang G; Yuen PW; Zak M; Dragovich PS
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5488-97. PubMed ID: 24021463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.